Viewing Study NCT00421369


Ignite Creation Date: 2025-12-24 @ 10:48 PM
Ignite Modification Date: 2025-12-31 @ 3:21 AM
Study NCT ID: NCT00421369
Status: COMPLETED
Last Update Posted: 2013-03-22
First Post: 2007-01-11
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Augmentation of the Antidepressant Action of Sertraline With Triiodothyronine (T3)and Reboxetine: Clinical Efficacy, Adverse Effects and Predictors of Response.
Sponsor: Hadassah Medical Organization
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: t3rbx-HMO-CTIL
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: None
Responsible Party Affiliation:
Old Name: Dr. rena Cooper
Old Organization: HADASSAH MEDICAL ORGANIZATION

Collaborators